Nautilus Biotechnology, Inc.
NASDAQ:NAUT
1.76 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 19.397 | 114.523 | 185.619 | 36.607 | 0.595 | 1.198 |
| Short Term Investments
| 154.021 | 69.948 | 160.11 | 40.135 | 16.064 | 144,488.284 |
| Cash and Short Term Investments
| 173.418 | 184.471 | 345.729 | 76.742 | 16.659 | 144,489.482 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 3.419 | 2.738 | 6.986 | 0.304 | 0.305 | -144,488.15 |
| Total Current Assets
| 176.837 | 187.209 | 349.222 | 77.659 | 16.964 | 1.332 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 36.901 | 32.566 | 31.86 | 6.213 | 1.119 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 90.647 | 129.169 | 16.371 | 0.612 | 147.842 | 144.488 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.18 | 1.108 | 0.997 | 0.527 | -147.383 | 0 |
| Total Non-Current Assets
| 128.728 | 162.843 | 49.228 | 7.352 | 1.578 | 144.488 |
| Total Assets
| 305.565 | 350.052 | 398.45 | 85.011 | 18.542 | 145.821 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 1.639 | 1.272 | 1.723 | 0.47 | 0.289 | 0 |
| Short Term Debt
| 7.076 | 3.982 | 1.94 | 1.479 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| -0.948 | 0 | 2.731 | 0.936 | 0 | 0 |
| Other Current Liabilities
| 0.407 | 1.537 | 2.149 | 1.069 | 0.201 | 0.005 |
| Total Current Liabilities
| 9.122 | 6.791 | 5.812 | 3.018 | 0.49 | 0.005 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 31.09 | 28.337 | 29.062 | 3.296 | 275 | 5 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 108.418 | -275 | 0 |
| Total Non-Current Liabilities
| 31.09 | 28.337 | 29.062 | 111.714 | 275 | 5 |
| Total Liabilities
| 40.212 | 35.128 | 34.874 | 114.732 | 0.49 | 140.821 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 398.45 | 0.108 | 32.561 | 0 |
| Common Stock
| 0.013 | 0.012 | 0.012 | 0.001 | 0.001 | 0 |
| Retained Earnings
| -202.239 | -138.564 | -80.64 | -30.325 | -14.706 | 0.627 |
| Accumulated Other Comprehensive Income/Loss
| -0.255 | -1.854 | -0.184 | 0.003 | 0.007 | 0 |
| Other Total Stockholders Equity
| 467.834 | 455.33 | 444.388 | 0.6 | 0.189 | 4.373 |
| Total Shareholders Equity
| 265.353 | 314.924 | 363.576 | -29.721 | 18.052 | 5 |
| Total Equity
| 265.353 | 314.924 | 363.576 | -29.721 | 18.052 | 5 |
| Total Liabilities & Shareholders Equity
| 305.565 | 350.052 | 398.45 | 85.011 | 18.542 | 145.821 |